Caris Life Sciences, Inc. (CAI)
19.29
+0.16
(+0.84%)
USD |
NASDAQ |
Apr 02, 16:00
19.28
0.00 (0.00%)
After-Hours: 20:00
Caris Life Sciences Total Liabilities (Quarterly) : 548.36M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Neurocrine Biosciences, Inc. | 1.500B |
| Glaukos Corp. | 274.22M |
| Edgewise Therapeutics, Inc. | 30.35M |
| Nuvalent, Inc. | 164.37M |
| Alphatec Holdings, Inc. | 755.18M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.126B |
| Shareholders Equity (Quarterly) | 577.31M |
| Debt to Equity Ratio | 0.7408 |
| Current Ratio | 7.848 |
| Net Debt Paydown Yield | -1.12% |